| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4033088 | Survey of Ophthalmology | 2007 | 8 Pages |
Abstract
Anecortave acetate is a unique ocular angiostatic cortisene that has broad-based anti-angiogenic activity in 14 different preclinical models of neovascularization, across multiple species and inducers of neovascularization. Anecortave acetate is being tested clinically for inhibition of choroidal neovascularization associated with age-related macular degeneration.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Abbot F. PhD,